Tivity Health, Inc. (NASDAQ:TVTY) Q2 2019 Earnings Conference Call - Final Transcript

Aug 07, 2019 • 05:00 pm ET


Tivity Health, Inc. (NASDAQ:TVTY) Q2 2019 Earnings Conference Call - Final Transcript


Loading Event

Loading Transcript


Good afternoon, and welcome to the Tivity Health Second Quarter 2019 Financial Results Conference Call. Today's call is being recorded and will be available for replay beginning today and through August 14th, 2019 by dialing 800-585-8367. The replay passcode is 9579725. The replay may also be accessed for the next 12 months on the company's website. [Operator Instructions]

To the extent that any non-GAAP financial measures are discussed on today's call, you will be able to find a reconciliation of the measure to the most directly comparable financial measure calculated in accordance with GAAP on today's news release, which is also posted on the company's website. This conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements, among others, regarding Tivity Health's expected quarterly and annual operating and financial performance for 2019 and beyond. For this purpose, any statements made during this call that are not statements of historical fact may be deemed to be forward-looking


Without limiting the foregoing, the words believes, anticipates, plans, expects and similar expressions are intended to identify forward-looking statements. You are hereby cautioned that these statements may be affected by the important factors, among others, set forth in Tivity Health's filings with the Security and Exchange Commission and in today's news release. And consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements. The company undertakes no obligation to update publicly any forward-looking statements whether as a result of new information, future events or otherwise.

And now I would like to turn the call over to the company's Chief Executive Officer, Mr. Donato Tramuto. You may begin, sir.

Donato J. Tramuto

Welcome and thank you to everyone who has joined the call today. I have with me Dawn Zier, Tivity Health's President and Chief Operating Officer and former CEO of Nutrisystem; Adam Holland, our CFO; as well as Tommy Lewis, our Investor Relations and integration initiatives, who will be available during this -- during the question-and-answer session following our prepared remarks.

Before we provide an update on our progress, I want to take this moment to remember Chip Wochomurka, who passed away last week after battling brain cancer for the last 18 months. Those of us who worked closely with him knew Chip as a dedicated professional whose commitment to the success of this company was unwavering. He will be missed and his contributions will be everlasting and we send our warm thoughts and condolences to his wife, Jane and their three sons.

I will begin today with an overview of our enterprise level results and then discuss the Healthcare business unit. Don will provide an update on the Nutrition business unit, Adam will cover the financials, as well as our outlook. But first, allow me a moment to highlight the core strengths of the company. Our business clearly aligns with the needs of our health plan customers, SilverSneakers members and where policymakers are directing the future of healthcare, namely to